To this end, tumor-infiltrating immune cells in the tumor parenchyma and associated stroma and PD-L1 status (TPS, CPS, IC) were quantified, and the results were correlated with patient survival and clinicopathological parameters. The gene discussed is CD274; the disease is neoplasm.